Rizik maligniteta u čvoru štitnjače kod nalaza atipije neodređene značajnosti na citološkoj punkciji: kliničko iskustvo iz tercijarne ustanove by Josip Staničić et al.
Acta Clin Croat 2019; 58:333-336 Original Scientific Paper
doi: 10.20471/acc.2019.58.02.17
Acta Clin Croat, Vol. 58, No. 2, 2019  333
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SuMMAry – The Bethesda System for reporting Thyroid Cytopathology from 2009 introduced 
a new category in thyroid nodule fine-needle aspiration (fnA) findings named atypia of undeter-
mined significance (AuS), which usually appears in around 5% of fnA findings. Our study aimed to 
assess the utility of AuS finding in determining the risk of malignancy in thyroid nodules. in our 
study, 160 patients with AuS finding on initial fnA were regularly followed-up. total and specific 
malignancy rates were calculated after receiving histopathologic confirmation or histopathologic/cy-
tologic exclusion of malignancy. eventually 80 (50%) patients were referred to surgery, with malig-
nancy rate of 37.5% on histopathology. Another 52 (32.5%) patients were confirmed to have benign 
nodules on repeat fnA. After combining results obtained from histopathologic reports with those 
obtained from cytologic follow-up, total malignancy rate was 22.72%. however, malignancy was con-
firmed in only one (5.26%) of 19 patients with AuS finding on repeat fnA with surgical and histo-
pathologic follow-up. in conclusion, fnA is an extremely useful tool for clinicians to discriminate 
patients to be referred to surgery and those that can be followed-up safely without the need for further 
invasive procedures.
key words: Biopsy, fine-needle; Thyroid nodule; Thyroid neoplasms; Cytodiagnosis; Adenocarcinoma, 
 follicular
Correspondence to: Josip Staničić, MD, department of Oncology 
and nuclear Medicine, Sestre milosrdnice university hospital 
Centre, Vinogradska c. 29, hr-10000 Zagreb, Croatia
e-mail: josip.stanicic@kbcsm.hr
received May 5, 2017, accepted november 16, 2018
Introduction
Since its introduction in the 1960s, fine-needle as-
piration biopsy (fnA) has become an indispensable 
tool for clinicians in thyroid cancer diagnostics. it has 
the ability to pinpoint suspicious thyroid nodules ac-
curately for malignancy, but also to almost completely 
exclude the possibility of malignancy in case of benign 
finding1. The Bethesda System for reporting Thyroid 
Cytopathology (BSrtC) from 2009 introduced a new 
category in thyroid nodule fnA findings named atyp-
ia of undetermined significance (AuS)2. in 2012, the 
Croatian Society for Clinical Cytology, on the basis of 
data reported in the literature and own experience, 
implemented the following 4-tiered diagnostic scheme: 
non-diagnostic category, benign lesions, indeterminate 
lesions, and malignant neoplasm category3. The cate-
gory of indeterminate lesions comprises a large spec-
trum of lesions with cytologic features more or less 
suggestive of but not diagnostic for malignancy. More 
common in this category are AuS, follicular neoplasm, 
hürthle cell neoplasm and suspicious of papillary car-
cinoma. individual approach is recommended and, in 
most cases, clinical data and ancillary methods deter-
mine further treatment.
The term AuS is reserved for specimens that con-
tain cells (follicular, lymphoid, or other) with architec-
tural and/or nuclear atypia that is not sufficient to be 
classified as suspicious of follicular neoplasm, suspi-
cious of malignancy, or malignant2. Most AuS cases 
are based on follicular cell atypia, but in rare cases, the 
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AuS designation may be appropriate for a non-follic-
ular and even non-epithelial atypia. According to lit-
erature data, the risk of malignancy in these nodules 
ranges from 5% to 20%2,4,5,6.
Our study aimed to assess the utility of AuS find-
ing in determining the risk of malignancy in thyroid 
nodules. This type of study has not yet been performed 
in Croatia.
Patients and Methods
A total of 160 patients referred from department 
of Oncology and nuclear Medicine, Sestre milosrd-
nice university hospital Centre, Zagreb, Croatia, with 
AuS finding in one of their thyroid nodules were reg-
ularly followed-up. during their regular follow-up vis-
its, thyroid hormones, ultrasonography (uS) and, in 
most cases, repeat fnA were performed. Patients with 
benign finding on repeat fnA were classified as be-
nign; those with malignant finding or finding suspi-
cious of malignancy were immediately referred to head 
and neck surgeon for total thyroidectomy. Patients 
with AuS finding on multiple repeat fnAs were re-
ferred to further follow-up. in these cases, uS finding 
was especially important for being able to determine 
the increase in the respective nodule size and changes 
in its morphology that could indicate malignant trans-
formation.
After the classification was completed, the rate of 
malignant nodules and the rate of nodules suspicious 
of malignancy after repeat fnA in our sample was cal-
culated and compared to data from the literature. in 
addition, the rate of benign findings on repeat fnA 
was calculated, as well as the rate of continued AuS 
findings on repeat fnA. After the surgery was per-
formed on patients with suspicious nodules, the rate of 
malignancy was calculated for all groups of patients 
and combined with the data obtained on follow-up to 
yield a complete report of the risk of malignancy in 
patients with AuS finding in thyroid nodules.
Results
A total of 3550 patients had one or more fnAs 
performed on one or more thyroid nodules at our de-
partment from 2011 until 2015. Of these, 187 patients 
(15 male and 171 female) had an AuS finding on 
fnA (5.26%). during that period, 27 patients were 
lost from follow-up. Most of the patients were referred 
to repeat fnA, but some were immediately referred to 
surgery without repeat fnA, mostly due to nodule 
size and suspicious morphology on uS. Patients with 
malignant finding or finding suspicious of malignancy 
Table 2. Total malignancy rate in patients after initial 
AUS FNA finding
Patients with initial 
AuS fnA finding total Male female
Malignant  
(all with histologic 
confirmation)
30 (22.72%) 2 28
Benign (including 
patients with clinical 
follow-up)
102 (77.28%) 3 99
total 132 5 127
AuS = atypia of undetermined significance; fnA = fine-needle as-
piration
Table 1. Follow-up of patients after AUS finding on initial FNA
repeat fnA after initial AuS no. of patients  referred to surgery histopathologic reportMalignant Benign
not performed 35 (21.88%) 35 (100%) 12 (34.29%) 23 (65.71%)
Malignant 11 (6.88%) 11 (100%) 10 (90.91%) 1 (9.09%)
Suspicious of malignancy 11 (6.88%) 11 (100%) 6 (54.55%) 5 (45.45%)
AuS 45 (28.13%) 19 (40.91%) 1 (5.26%) 18 (94.74%)
follicular neoplasm 6 (3.75%) 4 (66.67%) 1 (25%) 3 (75%)
Benign 52 (32.5%) 0
total 160 (100%) 80 30 (37.5%) 50 (62.5%)
AuS = atypia of undetermined significance; fnA = fine-needle aspiration
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on repeat fnA were immediately referred to surgery. 
Most of the patients with AuS finding on repeat fnA 
went on to be monitored with uS for nodule size and 
morphology. however, even some of those patients 
were referred to surgery, mostly due to the size of their 
nodules. eventually, 80 (4 male and 76 female) pa-
tients with AuS finding on initial fnA were referred 
to surgery, with a malignancy rate of 37.5% on histo-
pathology. detailed summary of patient follow-up is 
shown in table 1.
After coupling results obtained from histopatho-
logic reports with those obtained from clinical follow-
up, and after excluding 28 patients with still indeter-
minate lesions on repeat fnA, the malignancy rate for 
132 patients with initial AuS finding on fnA was 
22.72%. detailed summary is shown in table 2.
Discussion
Thyroid nodules are the most common thyroid pa-
thology, with almost 50% of the population affected7. 
The principal issue with thyroid nodules is the possi-
bility of malignancy in some of these nodules. The in-
troduction of uS and fnA gave the clinicians an in-
dispensable tool in thyroid cancer diagnostics, but also 
created some problems, which include over-diagnos-
tics and false-positive results, which lead to unneces-
sary thyroidectomy8. trying to further improve the 
diagnostic criteria, a group of most prominent cytolo-
gists introduced BSrtC as a new classification in 
2009, which included a new category of AuS com-
prising all those findings not easily included into be-
nign, suspicious or malignant categories. This category 
principally includes cases with nuclear and/or archi-
tectural atypia, which are not sufficient to mark them 
as malignant neoplasms2.
generally, the AuS finding accounts for 3% to 
10% of all thyroid fnA findings4,5,9. Our experience is 
generally in line with data from the literature, with 
5.26% of thyroid fnAs resulting in AuS. data from 
the literature indicate that malignancy risk in nodules 
with AuS ranges from 15% to 25%5,10, but it usually 
includes only patients with histologic follow-up. in 
our study, 50% of patients with initial AuS fnA find-
ing were eventually referred to surgery, and malignan-
cy rate among them was 37.5%. Thirty five (21.88%) of 
160 patients were immediately referred to surgery 
without further diagnostic follow-up, mainly due to 
the size of the nodules or their morphology on uS. 
eventually, most of the patients were proven to have 
benign nodules, or continued to have AuS finding on 
repeat fnA. however, malignancy or suspicious ma-
lignancy on repeat fnA was found in 22 (17.6%) pa-
tients with initial AuS fnA finding, prompting im-
mediate surgery. eventually, 30 out of 132 patients 
with AuS finding on initial fnA and with surgical/
clinical follow-up were proven to have malignant thy-
roid nodules, with a malignancy rate of 22.72%. inter-
estingly, malignancy was confirmed in only one 
(5.26%) of 19 patients with AuS finding on repeat 
fnA with surgical and histopathologic follow-up.
what does an AuS finding on fnA of thyroid 
nodule tell the clinician in regular practice? it certainly 
raises suspicion of malignancy for the nodule in ques-
tion and urges the clinician to follow-up the patient 
and order repeat fnA of the nodule. Many of those 
nodules on repeat fnA are classified as benign nod-
ules, but a small percentage fall into malignant catego-
ry and require surgery. dilemma remains on how to 
proceed with patients whose nodules yield an AuS 
finding even on repeat fnA.
Our practice in these cases is to repeat fnA for 
two more times. if both fnAs result in AuS finding, 
we continue to follow-up these patients with uS that 
can precisely monitor nodule size and morphology 
and report any changes with high specificity prompt-
ing another repeat fnA, primarily since, as our study 
revealed, the risk of malignancy in these nodules re-
mains very low. however, since fnA is not the only 
criterion in determining whether surgery is needed, it 
is up to the clinician to resolve how to proceed in these 
cases, where his experience can often be the decisive 
factor.
Conclusion
fine-needle aspiration is an extremely useful tool 
for clinicians to discriminate patients to be referred to 
the surgeon. in our study, we found that AuS finding 
on fnA showed a general risk of malignancy in thy-
roid nodule of 22.72%. This figure is not insignificant 
and prompts further diagnostic follow-up by the clini-
cian to determine which patients should be referred to 
surgery, and which can be followed-up safely without 
the need for further invasive procedures, especially 
since in our study, malignancy was confirmed in only 
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5.26% of patients with AuS finding on repeat fnA 
with surgical and histopathologic follow-up.
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Sažetak
riZik MAlignitetA u ČVOru ŠtitnJAČe kOd nAlAZA AtiPiJe neOdreĐene  
ZnAČAJnOSti nA CitOlOŠkOJ PunkCiJi: kliniČkO iSkuStVO iZ terCiJArne uStAnOVe
J. Staničić, D. Kust, N. Mateša i Z. Kusić
kroz Sustav Bethesda za citološku analizu štitnjače 2009. godine uvedena je nova kategorija u nalazima citološke punk-
cije čvorova u štitnjači pod nazivom atipija neodređene značajnosti (AuS), koja se obično pojavljuje u oko 5% nalaza. Ovom 
studijom željeli smo procijeniti korist nalaza AuS u određivanju rizika maligniteta u čvorovima štitnjače. u našoj studiji 
pratili smo ukupno 160 bolesnika s nalazom AuS na početnoj citološkoj punkciji. nakon patohistološke potvrde ili cito-
loškog/patohistološkog isključivanja maligniteta u navedenom čvoru izračunali smo ukupni i specifični rizik maligniteta. 
ukupno je 80 (50%) bolesnika bilo upućeno na operacijski zahvat, od čega je ukupno 37,5% imalo patohistološki potvrđen 
rak štitnjače. Benigni čvorovi bili su dokazani ponovljenom citološkom punkcijom u još 52 (32,5%) bolesnika. ukupni udio 
malignih čvorova nakon udruživanja rezultata patohistologije s rezultatima ponovljene citološke punkcije iznosio je 22,72%. 
ipak, samo je jednom (5,26%) od 19 bolesnika koji su bili poslani na operaciju nakon višestrukog nalaza AuS na ponovljenim 
punkcijama patohistološki potvrđen karcinom štitnjače. Citološka punkcija je izrazito koristan dijagnostički postupak za 
odabir bolesnika koje bi trebalo uputiti na operaciju štitnjače nasuprot onima koji se mogu sigurno pratiti bez rizika provo-
đenja invazivnih zahvata.
ključne riječi: Biopsija tankom iglom; Tireoideja, čvor; Tireoidni tumori; Citodijagnostika; Adenokarcinom, folikularni
